Pharma-Bio Serv, Inc. Quarterly Revenues in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Pharma-Bio Serv, Inc. quarterly/annual Revenues history and growth rate from Q1 2017 to Q2 2024.
  • Pharma-Bio Serv, Inc. Revenues for the quarter ending July 31, 2024 was $2.42M, a 47.2% decline year-over-year.
  • Pharma-Bio Serv, Inc. Revenues for the twelve months ending July 31, 2024 was $10.8M, a 40.2% decline year-over-year.
  • Pharma-Bio Serv, Inc. annual Revenues for 2023 was $17M, a 12.5% decline from 2022.
  • Pharma-Bio Serv, Inc. annual Revenues for 2022 was $19.4M, a 3.56% decline from 2021.
  • Pharma-Bio Serv, Inc. annual Revenues for 2021 was $20.1M, a 6.72% decline from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $10.8M $2.42M -$2.16M -47.2% May 1, 2024 Jul 31, 2024 10-Q 2024-09-16
Q1 2024 $12.9M $2.38M -$2.19M -47.9% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-14
Q4 2023 $15.1M $2.38M -$1.86M -43.8% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-18
Q3 2023 $17M $3.6M -$1.04M -22.4% Aug 1, 2023 Oct 31, 2023 10-K 2024-01-29
Q2 2023 $18M $4.58M -$197K -4.13% May 1, 2023 Jul 31, 2023 10-Q 2024-09-16
Q1 2023 $18.2M $4.56M -$404K -8.14% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-14
Q4 2022 $18.6M $4.24M -$781K -15.6% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-18
Q3 2022 $19.4M $4.64M -$959K -17.1% Aug 1, 2022 Oct 31, 2022 10-K 2024-01-29
Q2 2022 $20.4M $4.77M -$214K -4.29% May 1, 2022 Jul 31, 2022 10-Q 2023-09-14
Q1 2022 $20.6M $4.97M -$74.3K -1.48% Jan 31, 2022 Apr 30, 2022 10-Q 2022-06-14
Q4 2021 $20.6M $5.02M +$531K +11.8% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-17
Q3 2021 $20.1M $5.6M +$572K +11.4% Aug 1, 2021 Oct 31, 2021 10-K 2023-01-30
Q2 2021 $19.5M $4.99M -$1.29M -20.6% May 1, 2021 Jul 31, 2021 10-Q 2022-09-14
Q1 2021 $20.8M $5.04M -$606K -10.7% Jan 31, 2021 Apr 30, 2021 10-Q 2022-06-14
Q4 2020 $21.4M $4.49M -$125K -2.71% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-17
Q3 2020 $21.6M $5.03M +$201K +4.17% Aug 1, 2020 Oct 31, 2020 10-K 2022-02-11
Q2 2020 $21.4M $6.28M +$1.31M +26.4% May 1, 2020 Jul 31, 2020 10-Q 2021-09-14
Q1 2020 $20.1M $5.65M +$497K +9.66% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-14
Q4 2019 $19.6M $4.61M +$47K +1.03% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-17
Q3 2019 $19.5M $4.82M -$850K -15% Aug 1, 2019 Oct 31, 2019 10-K 2021-02-01
Q2 2019 $20.4M $4.97M +$335K +7.24% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q1 2019 $20M $5.15M +$1.38M +36.8% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-15
Q4 2018 $18.6M $4.57M +$840K +22.5% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-16
Q3 2018 $17.8M $5.67M Aug 1, 2018 Oct 31, 2018 10-K 2020-01-29
Q2 2018 $4.63M +$651K +16.4% May 1, 2018 Jul 31, 2018 10-Q 2019-09-16
Q1 2018 $3.77M -$156K -3.97% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-14
Q4 2017 $3.73M Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-18
Q2 2017 $3.98M May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q1 2017 $3.92M Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.